Granulomatosis with Polyangiitis Drug and Forecast Market

List of Tables
Table 1. Key Players of Granulomatosis with Polyangiitis Drug in Global Market
Table 2. Top Granulomatosis with Polyangiitis Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Granulomatosis with Polyangiitis Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Granulomatosis with Polyangiitis Drug Revenue Share by Companies, 2018-2023
Table 5. Global Granulomatosis with Polyangiitis Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Granulomatosis with Polyangiitis Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Granulomatosis with Polyangiitis Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Granulomatosis with Polyangiitis Drug Product Type
Table 9. List of Global Tier 1 Granulomatosis with Polyangiitis Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Granulomatosis with Polyangiitis Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2024-2035
Table 16. By Application ? Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2024-2035
Table 21. By Region ? Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2024-2035
Table 26. By Country - North America Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2024-2035
Table 30. By Country - Europe Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2024-2035
Table 34. By Region - Asia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2024-2035
Table 38. By Country - South America Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2024-2035
Table 42. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2024-2035
Table 46. Bionovis SA Company Summary
Table 47. Bionovis SA Granulomatosis with Polyangiitis Drug Product Offerings
Table 48. Bionovis SA Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Bionovis SA Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Company Summary
Table 51. Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Product Offerings
Table 52. Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Bristol-Myers Squibb Company Key News & Latest Developments
Table 54. ChemoCentryx Inc Company Summary
Table 55. ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Product Offerings
Table 56. ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. ChemoCentryx Inc Key News & Latest Developments
Table 58. Coherus BioSciences Inc Company Summary
Table 59. Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Product Offerings
Table 60. Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Coherus BioSciences Inc Key News & Latest Developments
Table 62. Genor BioPharma Co Ltd Company Summary
Table 63. Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Product Offerings
Table 64. Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Genor BioPharma Co Ltd Key News & Latest Developments
Table 66. GlaxoSmithKline Plc Company Summary
Table 67. GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Product Offerings
Table 68. GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. GlaxoSmithKline Plc Key News & Latest Developments
Table 70. Iltoo Pharma Company Summary
Table 71. Iltoo Pharma Granulomatosis with Polyangiitis Drug Product Offerings
Table 72. Iltoo Pharma Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Iltoo Pharma Key News & Latest Developments
Table 74. Panacea Biotec Ltd Company Summary
Table 75. Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Product Offerings
Table 76. Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Panacea Biotec Ltd Key News & Latest Developments
Table 78. Sandoz International GmbH Company Summary
Table 79. Sandoz International GmbH Granulomatosis with Polyangiitis Drug Product Offerings
Table 80. Sandoz International GmbH Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Sandoz International GmbH Key News & Latest Developments
Table 82. The International Biotechnology Center (IBC) Generium Company Summary
Table 83. The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Product Offerings
Table 84. The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. The International Biotechnology Center (IBC) Generium Key News & Latest Developments
Table 86. Granulomatosis with Polyangiitis Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 87. Global Granulomatosis with Polyangiitis Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Granulomatosis with Polyangiitis Drug Production by Region, 2018-2023 (K Pcs)
Table 89. Global Granulomatosis with Polyangiitis Drug Production by Region, 2024-2035 (K Pcs)
Table 90. Granulomatosis with Polyangiitis Drug Market Opportunities & Trends in Global Market
Table 91. Granulomatosis with Polyangiitis Drug Market Drivers in Global Market
Table 92. Granulomatosis with Polyangiitis Drug Market Restraints in Global Market
Table 93. Granulomatosis with Polyangiitis Drug Raw Materials
Table 94. Granulomatosis with Polyangiitis Drug Raw Materials Suppliers in Global Market
Table 95. Typical Granulomatosis with Polyangiitis Drug Downstream
Table 96. Granulomatosis with Polyangiitis Drug Downstream Clients in Global Market
Table 97. Granulomatosis with Polyangiitis Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Granulomatosis with Polyangiitis Drug Segment by Type in 2022
Figure 2. Granulomatosis with Polyangiitis Drug Segment by Application in 2022
Figure 3. Global Granulomatosis with Polyangiitis Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Granulomatosis with Polyangiitis Drug Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Granulomatosis with Polyangiitis Drug Revenue, 2018-2035 (US$, Mn)
Figure 7. Granulomatosis with Polyangiitis Drug Sales in Global Market: 2018-2035 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Granulomatosis with Polyangiitis Drug Revenue in 2022
Figure 9. By Type - Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018-2035
Figure 11. By Type - Global Granulomatosis with Polyangiitis Drug Sales Market Share, 2018-2035
Figure 12. By Type - Global Granulomatosis with Polyangiitis Drug Price (USD/Pcs), 2018-2035
Figure 13. By Application - Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018-2035
Figure 15. By Application - Global Granulomatosis with Polyangiitis Drug Sales Market Share, 2018-2035
Figure 16. By Application - Global Granulomatosis with Polyangiitis Drug Price (USD/Pcs), 2018-2035
Figure 17. By Region - Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018-2035
Figure 20. By Region - Global Granulomatosis with Polyangiitis Drug Sales Market Share, 2018-2035
Figure 21. By Country - North America Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018-2035
Figure 22. By Country - North America Granulomatosis with Polyangiitis Drug Sales Market Share, 2018-2035
Figure 23. US Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Granulomatosis with Polyangiitis Drug Sales Market Share, 2018-2035
Figure 28. Germany Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 29. France Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Granulomatosis with Polyangiitis Drug Sales Market Share, 2018-2035
Figure 37. China Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 41. India Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018-2035
Figure 43. By Country - South America Granulomatosis with Polyangiitis Drug Sales Market Share, 2018-2035
Figure 44. Brazil Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Sales Market Share, 2018-2035
Figure 48. Turkey Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2018-2035
Figure 52. Global Granulomatosis with Polyangiitis Drug Production Capacity (K Pcs), 2018-2035
Figure 53. The Percentage of Production Granulomatosis with Polyangiitis Drug by Region, 2022 VS 2035
Figure 54. Granulomatosis with Polyangiitis Drug Industry Value Chain
Figure 55. Marketing Channels